Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit	Total
Stockholders equity, Beginning balance at Dec. 31, 2022	$ 2	$ 199,492	$ (35)	$ (161)	$ (150,266)	$ 49,032
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2022	23,312,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock		1				1
Vesting of restricted common stock (in shares)	3,945
Issuance of common stock upon stock option exercises		1,496				1,496
Issuance of common stock upon stock option exercises (in shares)	1,264,899
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs	$ 2	46,501				46,503
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs (in shares)	17,810,000
Vesting of restricted stock units, net of withholding			(24)			(24)
Vesting of restricted stock units, net of withholding (in shares)	31,158
Stock-based compensation		3,335				3,335
Unrealized gain (loss) on marketable securities				170		170
Net Income (Loss)					(45,704)	(45,704)
Stockholders equity, Ending balance at Dec. 31, 2023	$ 4	250,825	(59)	9	(195,970)	54,809
Stockholders equity, Ending balance (in shares) at Dec. 31, 2023	42,422,531
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon at-the-market offering, net of issuance costs	$ 1	44,206				44,207
Issuance of common stock upon at-the-market offering, net of issuance costs (in shares)	11,625,295
Issuance of common stock upon stock option exercises		499				$ 499
Issuance of common stock upon stock option exercises (in shares)	379,425					379,425
Issuance of common stock upon exercise of common warrants		450				$ 450
Issuance of common stock upon exercise of common warrants (in shares)	200,000
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs	$ 1	(1)
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs (in shares)	4,439,836
Issuance of warrants upon amendment of debt facility		261				261
Vesting of restricted stock units, net of withholding			(48)			(48)
Vesting of restricted stock units, net of withholding (in shares)	64,062
Stock-based compensation		4,280				4,280
Unrealized gain (loss) on marketable securities				52		52
Net Income (Loss)					(44,485)	(44,485)
Stockholders equity, Ending balance at Dec. 31, 2024	$ 6	$ 300,520	$ (107)	$ 61	$ (240,455)	$ 60,025
Stockholders equity, Ending balance (in shares) at Dec. 31, 2024	59,131,149